The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
NCT Number: NCT04812444
Clinical study on safety and efficacy of Zylox peripheral venous stent system in the treatment of iliac vein stenosis or occlusion.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Chongqing, Chongqing Municipality, China
The purpose of this study was to evaluate the safety and efficacy of Zylox peripheral venous stent system in the treatment of iliac vein stenosis or occlusive lesions compare with conventional venous stent.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Self-expanding stent implantation during the index procedure.
Self-expanding stent implantation during the index procedure.
Time frame: 12 months
Target vascular patency rate
Time frame: 12 months
Related to death of clinical trials
Time frame: Preoperative、Intraoperative、up to 1 month、3 month、6 month、12 month、2 years、3 years、5 years
Adverse medical events,whether or not related to the medical device
Zhejiang Zylox Medical Device Co., Ltd.
Industry
Safety and Efficacy of Peripheral Venous Stent System in the Treatment of Patients With Iliac Vein Stenosis or Occlusion: a Prospective, Multicentre, Randomized Controlled Clinical Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05324787
Iliac Vein Occlusion, Iliac Vein Stenosis
Beijing, China
View Trial DetailsNCT04694248
Cardiovascular Abnormalities, Cardiovascular Diseases
Hangzhou, Zhejiang, China
View Trial Details